Dissociative Anesthetic: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 8: | Line 8: | ||
===Excited Delirium Syndrome=== | ===Excited Delirium Syndrome=== | ||
[[ | [[Ketamine|KETAMINE (KETALAR)]] 4 mg/kg IM x 1 dose (2 mg/kg IVP) | ||
===Combative Head Injury=== | ===Combative Head Injury=== | ||
[[ | [[Ketamine|KETAMINE (KETALAR)]] 2 mg/kg IVP or IN OR 4 mg/kg IM x 1 dose <br /> | ||
[[Morphine_Sulfate|MORPHINE SULFATE]] 2 - 20 mg IV, IM or IN, titrated to effect. | |||
[[ | |||
Latest revision as of 20:30, 22 April 2020
Section 2 - PRIMARY CARE
2.06 DISSOCIATIVE ANESTHETIC
"THE BELOW MEDICATION MAY CAUSE A DECREASED LOC AND COULD COMPROMISE A PATIENT’S AIRWAY. JUDICIOUS USE IS A MUST! ALLOW AMPLE TIME FOR DOSE TO TAKE EFFECT."
Procedure
Ketamine is a dissociative anesthetic which temporarily takes over chemical receptors in the brain blocking pain receptors causing sedation and easing pain.
Excited Delirium Syndrome
KETAMINE (KETALAR) 4 mg/kg IM x 1 dose (2 mg/kg IVP)
Combative Head Injury
KETAMINE (KETALAR) 2 mg/kg IVP or IN OR 4 mg/kg IM x 1 dose
MORPHINE SULFATE 2 - 20 mg IV, IM or IN, titrated to effect.